-
Reed soars to early Masters lead on wings of eagles
-
US Democrats fail in bid to curb Trump's Iran war powers
-
Veteran prop Slimani to return to France with Toulon
-
Iranians pay tribute to slain supreme leader weeks after killing
-
Russian police raid independent Novaya Gazeta media outlet
-
Barton Snow completes Cheltenham-Aintree double in Foxhunters Chase
-
IMF to cut global growth forecast due to Mideast war
-
Jihadists kill Nigerian troops including senior brigadier general
-
Local boy Aranburu sprints to Basque Country stage, Seixas extends lead
-
Russia brands Nobel Prize-winning rights group Memorial 'extremist'
-
England set for World Cup warm-up friendlies in Florida heat
-
Sabalenka pulls out of Stuttgart Open with injury
-
BTS kick off world tour with spectacular South Korea show
-
UK animal charity rescues over 250 dogs from single home
-
Barton Snow has a lot to crow about in Foxhunters Chase
-
Reigning champion Nick Rockett out of Grand National
-
'Free' McIlroy launches his Masters repeat bid
-
US envoy warns EU won't win AI race 'bringing others down'
-
Trump, Vance not 'meddling' in Hungary vote, says US envoy to EU
-
Jihadists kill 18 Nigerian troops including senior brigadier general
-
Mideast war threatens Africa's supply of humanitarian medicine
-
Seven World Cup winners start for England in Women's Six Nations opener
-
China FM vows deeper ties with North Korea on trip to Pyongyang
-
Sinner survives energy dip, end of streak to see off Machac
-
IMF expects to provide vulnerable economies hit by Iran war up to $50 bn
-
Oil prices jump back toward $100 on Mideast ceasefire doubts
-
Player tells Tiger to 'get a chauffeur'
-
Believers rejoice as Jerusalem's holy sites re-open
-
EU lawmakers want to tax Big Tech to fund budget
-
Croke Park boss eager to stage Fury-Joshua heavyweight clash in Dublin
-
Cannes Festival promises escapism in Hollywood-lite edition
-
Stabbed for saying no: Is online misogyny fueling violence in Brazil?
-
Russia's Nobel Prize-winning rights group Memorial branded 'extremist'
-
McIlroy ready for early start as 90th Masters begins
-
Fonseca eases into Monte Carlo last eight meeting with Zverev
-
Verstappen set for fresh F1 angst as engineer nears Red Bull exit - reports
-
Farhadi, Almodovar, Zvyagintsev to vie for top Cannes Festival prize
-
Ambitious Como's Champions League bid tested by Serie A leaders Inter
-
Emperor penguins listed as endangered species: IUCN
-
Six new caps for France for women's Six Nations opener
-
Calls for US-Iran truce to extend to Lebanon after Israeli strikes
-
Nepal ex-PM Oli gives defiant message after release from custody
-
Despite Middle East truce, airlines fear long-term disruptions
-
Memorial: Russia's Nobel Prize winning rights group facing 'extremism' ban
-
Artemis crew's families enthralled by messages from space
-
Champions Cup 'heartbreak' driving Toulouse revenge mission
-
Shallow Indonesian quake damages houses, injures residents
-
Nepal ex-PM Oli released from custody after 12 days: police
-
'Chills': Artemis astronauts say lunar flyby still washing over them
-
Ukraine lets firms deploy air defences against Russian attacks
NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets
ATHENS, GEORGIA / ACCESS Newswire / September 23, 2025 / Good Salt™ Life, Inc., a wholly owned subsidiary of NDT Pharmaceuticals Inc. (OTCID:NDTP) ("NDTP" or the "Company"), today shared insight into its strategic initiative designed to build value through investments in sustainable, science-driven health and wellness brands that protect people, pets, and the planet. Good Salt Life targets the $148 billion global biosafety market with a vertically integrated approach that combines proprietary hardware and EPA-approved antimicrobial solutions.
At the heart of Good Salt Life's innovation is hypochlorous acid (HOCl), a naturally occurring substance produced by the human body to combat infection. Through proprietary electrolysis, Good Salt Life transforms salt and water into powerful, eco-friendly solutions for home care, pet wellness, skincare, and professional biosafety. The Company's products are non-toxic, family-safe, and environmentally conscious, meeting the highest performance standards backed by EPA registration and rigorous third-party testing.
Trusted by Industry Leaders
Good Salt Life's breakthrough technologies have earned the trust of leading organizations across multiple sectors, including:
Animal Health: Strengthening welfare and biosecurity outcomes in critical environments to reduce mortality and ensure human health.
Cruise Industry: Partnering with industry giants such as Virgin, Royal Caribbean, Carnival Corp, and Norwegian Cruise Line to establish new benchmarks for passenger health and safety at sea.
Education & Healthcare: Providing solutions to renowned institutions like the Baptist Hospital System and Cleveland Clinic, ensuring the safety of vulnerable populations in hospitals and schools.
Government & Nonprofits: Offering proven solutions for maintaining hygiene in the Tennessee State Prison System, NY State Prison, New York City Fire Department, and Ronald McDonald House.
Sports: Collaborating with the New York Yankees, Boston Red Sox, Tampa Bay Rays, and NCAA programs including Ole Miss, Alabama, Clemson, LSU, and WKU Football to enhance safety and health standards.
Retail and E-Commerce: Expanding reach through partnerships with major distributors such as Amazon, Chewy, Walmart, Staples, Ecolox Tech, Imperial Dade, Veritiv, and System Chemical, making innovative products accessible to consumers.
Driving Scalable Impact
From households to large institutions, Good Salt Life's solutions are reshaping the meaning of cleanliness and protection. Whether reducing pathogens in animal shelters, safeguarding healthcare workers on the frontlines, or ensuring cruise passengers travel with peace of mind, Good Salt Life is scaling across markets where safety and sustainability are essential.
Investing in the Future
Good Salt Life is also focused on next-generation technologies that extend beyond chemistry. With advancements in robotics, AI-driven automation, and pioneering indoor air quality sensors, Good Salt Life is building a holistic ecosystem of safety solutions. These innovations will reduce labor costs, improve efficiency, and provide proactive protection against emerging health risks.
Commitment to Responsibility
"Good Salt Life stands at the intersection of innovation and responsibility," said Zach O'Shea, President and CEO of NDT Pharmaceuticals. "We are not just creating products; we are building a platform for healthier living, animal welfare, and environmental stewardship. As we grow alongside world-class partners and distributors, our vision remains clear: to lead the global shift toward safer, cleaner, and more sustainable living for future generations."
About NDT Pharmaceuticals, Inc. (OTC:NDTP)
NDT Pharmaceuticals, Inc. (OTC:NDTP) is a publicly traded company focused on advancing innovative consumer health and wellness solutions. With its recent acquisition of Good Salt Life Inc., NDTP has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.
About Good Salt Life, Inc.
Good Salt Life is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.
Contact:
SOURCE: NDT Pharmaceuticals Inc.
View the original press release on ACCESS Newswire
H.Thompson--AT